Brief: Algernon Pharmaceuticals Appoints VP Research & Operations And Chief Medical Officer
01/03/2021 12:51
March 1 (Reuters) - Algernon Pharmaceuticals Inc AGN.CD :
* ALGERNON PHARMACEUTICALS APPOINTS VP RESEARCH & OPERATIONS
AND
CHIEF MEDICAL OFFICER
Source text for Eikon: ID:nGNX7Xl1Lx
Further company coverage: AGN.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Grey Matters Health
See all newsBrief: Grey Matters Announces The Closing Of Its Equity And Convertible Debenture Private Placement Totalling CAD $1.12 Million
Brief: Algernon Announces Additional Increase To Private Placement Financing
Brief: Algernon Health Announces Private Placement
Brief: Algernon Announces Closing Of The Private Placement Financing
Brief: Algernon Announces $1 Mln Private Placement